Pazopanib (GW-786034)

Pazopanib (GW-786034)

Catalog Number:
L002368481APE
Mfr. No.:
APE-A3022
Price:
$188
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Pazopanib is a potent and selective second generation multi-targeted receptor tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinases. It is involved in inhibiting signaling pathways, angiogenesis, and cell proliferation. Pazopanib exhibited excellent anti-angiogenic and anti-tumor activity and synergism was observed in combination with chemotherapeutic drugs in several mouse models of a variety of tumors, accompanied by desirable pharmacokinetics and oral bioavailability. It inhibits the intracellular tyrosine kinase portion of all the VEGFR subtypes, and exhibits distinct pharmacokinetic and toxicity profiles compared with other agents among VEGF signaling pathway inhibitors. Recent studies elucidated its importance of signaling cascades related to angiogenesis in the management of RCC.

      • Properties
        • Alternative Name
          Pazopanib, Votrient, GW786034B, GW 786034, GW-786034; 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
          CAS Number
          444731-52-6
          Molecular Formula
          C21H23N7O2S
          Molecular Weight
          437.52
          Purity
          98.00%
          Solubility
          insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL in DMSO
          Storage
          Desiccate at -20°C

          * For Research Use Only

    We Also Recommend

    P005091

    $236

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.